David Bikard
21Patents
3h-index
15Co-inventors
56Inventor score
Filing activity: Feb 7, 2014 → Jan 29, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9822372B2 | CRISPR-Cas component systems, methods and compositions for sequence manipulation | Physics | 152 | Active |
| US10660943B2 | Sequence specific antimicrobials | Chemistry; Metallurgy | 31 | Active |
| US11135273B2 | Sequence specific antimicrobials | Chemistry; Metallurgy | 9 | Active |
| US11452765B2 | Sequence specific antimicrobials | Chemistry; Metallurgy | 3 | Active |
| US11491210B2 | Sequence specific antimicrobials | Chemistry; Metallurgy | 3 | Active |
| US10808254B2 | Optimized vector for delivery in microbial populations | Emerging Cross-Sectional Technologies | 3 | Active |
| US11491209B2 | Sequence specific antimicrobials | Chemistry; Metallurgy | 3 | Active |
| US11918631B2 | Sequence specific antimicrobials | Chemistry; Metallurgy | 3 | Active |
| US11497797B2 | Sequence specific antimicrobials | Chemistry; Metallurgy | 3 | Active |
| US11357831B2 | Sequence-specific antimicrobials by blocking DNA repair | Emerging Cross-Sectional Technologies | 2 | Active |
| US11078490B2 | Optimized vector for delivery in microbial populations | Emerging Cross-Sectional Technologies | 2 | Active |
| US12285467B2 | Sequence specific antimicrobials | Chemistry; Metallurgy | 0 | Active |
| US12295993B2 | Sequence specific antimicrobials | Chemistry; Metallurgy | 0 | Active |
| US11725183B2 | Method of culturing segmented filamentous bacteria in vitro | Emerging Cross-Sectional Technologies | 0 | Active |
| US12285466B2 | Sequence specific antimicrobials | Chemistry; Metallurgy | 0 | Active |
| US12246061B2 | Sequence specific antimicrobials | Chemistry; Metallurgy | 0 | Active |
| US12214022B2 | Sequence-specific antimicrobials by blocking DNA repair | Emerging Cross-Sectional Technologies | 0 | Active |
| US11377645B2 | Compositions and methods using Cas9 with enhanced spacer acquisition function | Chemistry; Metallurgy | 0 | Active |
| US12168040B2 | Sequence specific antimicrobials | Chemistry; Metallurgy | 0 | Active |
| US11946056B2 | Optimized vector for delivery in microbial populations | Emerging Cross-Sectional Technologies | 0 | Active |
| US11905516B2 | Optimized vector for delivery in microbial populations | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.